These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 317767)

  • 1. [Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].
    Schnabel I; Fricke HJ; Jansa U; Lehmann G
    Z Gesamte Inn Med; 1979 Dec; 34(23):704-8. PubMed ID: 317767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte subpopulations in the peripheral blood during polychemotherapy of non-Hodgkin's lymphoma].
    Trepińska E; Burchardt K; Sokołowski K
    Pol Tyg Lek; 1985 Aug; 40(33):932-5. PubMed ID: 3877275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents].
    Urasiński I; Proniewska M; Schumacher K
    Acta Haematol Pol; 1979; 10(2):129-36. PubMed ID: 314215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term responders of non-Hodgkin's lymphoma: patients treated with combination chemotherapy].
    Nishihara R; Ohnoshi T; Oka A; Hayashi K; Sato M; Ueoka H; Yasuoka M; Sando Y; Kimura I
    Rinsho Ketsueki; 1982 Aug; 23(8):1192-7. PubMed ID: 6183469
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
    Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
    Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Chubachi A; Miura AB; Yamaguchi A; Nishimura S
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monitoring of lymphocyte subpopulations in non Hodgkin lymphoma patients during chemotherapy.
    Hołowiecki J; Japa J; Krawczyk-Kuliś M; Stella-Hołowiecka B; Rudzka E; Jarczok K; Kamińska H
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):837-43. PubMed ID: 312089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases.
    Jonsson V
    Scand J Haematol; 1975 Sep; 15(2):109-16. PubMed ID: 1081272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between chronic lymphocytic leukaemia (B-CLL) and non-Hodgkin lymphomas in the leukaemic phase by the mouse red blood cell rosette assay.
    Pecze K; Telek B; Kiss A; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):446-50. PubMed ID: 2431964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2 cases of successful treatment of gastric lymphoma by means of polychemotherapy].
    Borisov VI; Korobkova LI; Vashakmadze LA; Frank GA
    Sov Med; 1984; (3):118-9. PubMed ID: 6547007
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
    Sampi K; Honda T; Hattori M; Takayama S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in human lymphocyte subpopulation in Hodgkin's lymphoma.
    Rejthar A; Patera J; Rejtharová A; Hrdlicková N
    Neoplasma; 1976; 23(4):371-5. PubMed ID: 1087377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of therapy on the behavior of T and B-lymphocytes in patients with non-Hodgkin's lymphoma].
    Franke A; Spormann H; Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):872-7. PubMed ID: 6176513
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of recurrent lymphomas with vincristine, BCNU, doxorubicin, and prednisone (VBAP): a Southwest Oncology Group Study.
    Weick JK; Jones SE; Haut A; Fisher R; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):611-4. PubMed ID: 6166373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)].
    Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):323-9. PubMed ID: 6897859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.